Maximus Downgraded by Citigroup Inc. to “Neutral” (MMS)
Maximus (NYSE:MMS) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Friday, TheFlyOnTheWall.com reports.
Maximus (NYSE:MMS) opened at 47.23 on Friday. Maximus has a 52-week low of $34.65 and a 52-week high of $50.55. The stock has a 50-day moving average of $43.23 and a 200-day moving average of $43.12. The company has a market cap of $3.237 billion and a P/E ratio of 29.92.
Maximus (NYSE:MMS) last announced its earnings results on Thursday, February 6th. The company reported $0.48 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.42 by $0.06. The company had revenue of $406.60 million for the quarter, compared to the consensus estimate of $392.86 million. During the same quarter last year, the company posted $0.63 earnings per share. Maximus’s revenue was up 42.0% compared to the same quarter last year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, February 28th. Shareholders of record on Friday, February 14th will be given a dividend of 0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Wednesday, February 12th.
In other Maximus news, Insider Mark Andrekovich sold 4,302 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $50.01, for a total transaction of $215,143.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
A number of other analysts have also recently weighed in on MMS. Analysts at Zacks downgraded shares of Maximus from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, January 20th. They now have a $53.80 price target on the stock. Analysts at Jefferies Group raised their price target on shares of Maximus from $47.00 to $53.00 in a research note to investors on Monday, November 18th. They now have a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $54.93.
MAXIMUS, Inc is a provider of business process services (NYSE:MMS) to government health and human services agencies under its mission of Helping Government Serve the People.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.